<--- Back to Details
First PageDocument Content
Anatomy / Partial thromboplastin time / Coagulation / Prekallikrein / Factor XII / Von Willebrand disease / Prothrombin time / Pulmonary embolism / Antiphospholipid syndrome / Coagulation system / Blood / Medicine
Date: 2015-04-17 12:40:03
Anatomy
Partial thromboplastin time
Coagulation
Prekallikrein
Factor XII
Von Willebrand disease
Prothrombin time
Pulmonary embolism
Antiphospholipid syndrome
Coagulation system
Blood
Medicine

Journal of the Hong Kong Geriatrics Society • Vol. 8 No.1 DecReviewer’s comments: Dear Editor, This is a reasonably well written paper which makes a valid point. The main thrust of the paper

Add to Reading List

Source URL: www.hkgs.org

Download Document from Source Website

File Size: 25,46 KB

Share Document on Facebook

Similar Documents

en77  Original Article Improved Handling of Synonymous SNOMED CT Concepts used in HL7 Version 3 by the Example of the Von Willebrand Disease

en77 Original Article Improved Handling of Synonymous SNOMED CT Concepts used in HL7 Version 3 by the Example of the Von Willebrand Disease

DocID: 1uIQm - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1q38M - View Document

CrossMark_Color_flat+click

CrossMark_Color_flat+click

DocID: 1pLhl - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. ----------------------------DOSAGE FOR

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. ----------------------------DOSAGE FOR

DocID: 1odFQ - View Document